• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MMP-2 及其调节因子 TIMP2、MT1-MMP 和 IL-8 的低表达与前列腺癌有关。

Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.

机构信息

Laboratory of Medical Investigation-LIM55, Urology Department, University of Sao Paulo Medical School, Sao Paulo, Brazil.

出版信息

Int Braz J Urol. 2012 Mar-Apr;38(2):167-74. doi: 10.1590/s1677-55382012000200004.

DOI:10.1590/s1677-55382012000200004
PMID:22555040
Abstract

OBJECTIVE

Extracellular matrix homeostasis is strictly maintained by a coordinated balance between the expression of metalloproteinases (MMPs) and their regulators. The purpose of this study was to investigate whether MMP-2 and its specifi c regulators, TIMP-2, MT1-MMP and IL-8, are expressed in a reproducible, specific pattern and if the profiles are related to prognosis and clinical outcome of prostate cancer (PCa).

MATERIALS AND METHODS

MMP-2, TIMP-2, MT1-MMP and IL-8 expression levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) in freshly frozen malignant and benign tissue specimens collected from 79 patients with clinically localized PCa who underwent radical prostatectomies. The control group consisted of 11 patients with benign prostate hyperplasia (BPH). The expression profile of the MMP-2 and its regulators were compared using Gleason scores, pathological stage, pre-operative PSA levels and the fi nal outcome of the PCa.

RESULTS

The analysis of 79 specimens of PCa revealed that MMP-2, TIMP-2, MT1-MMP and IL-8 were underexpressed at 60.0%, 72.2%, 62.0% and 65.8%, respectively, in malignant prostatic tissue in relation to BPH samples. Considering the prognostic parameters, we demonstrated that high Gleason score tumors (≥ 7) overexpressed MMP-2 (p = 0.048) and TIMP-2 (p = 0.021), compared to low Gleason score tumors (< 7).

CONCLUSION

We have demonstrated that MMP-2 and its regulators are underexpressed in PCa. Alternatively, overexpression of MMP-2 and TIMP-2 was related to higher Gleason score tumors. We postulate that alterations in metalloproteinase expression may be important in the control of tissue homeostasis related to prostate carcinogenesis and tumor behavior.

摘要

目的

细胞外基质的动态平衡是通过基质金属蛋白酶(MMPs)及其调控因子的表达来严格维持的。本研究旨在探讨 MMP-2 及其特异性调节因子 TIMP-2、MT1-MMP 和 IL-8 是否以可重复的特异性模式表达,以及这些谱是否与前列腺癌(PCa)的预后和临床结局相关。

材料和方法

通过定量实时聚合酶链反应(qRT-PCR)分析 79 例接受根治性前列腺切除术的临床局限性 PCa 患者新鲜冷冻的恶性和良性组织标本中 MMP-2、TIMP-2、MT1-MMP 和 IL-8 的表达水平。对照组由 11 例良性前列腺增生(BPH)患者组成。比较 MMP-2 及其调节因子的表达谱与 Gleason 评分、病理分期、术前 PSA 水平和 PCa 的最终结果。

结果

对 79 例 PCa 标本的分析表明,与 BPH 样本相比,恶性前列腺组织中 MMP-2、TIMP-2、MT1-MMP 和 IL-8 的表达分别下调了 60.0%、72.2%、62.0%和 65.8%。考虑到预后参数,我们发现高 Gleason 评分(≥7)肿瘤(p=0.048)和 TIMP-2 过表达(p=0.021)比低 Gleason 评分(<7)肿瘤过表达。

结论

我们已经证明 MMP-2 及其调节因子在 PCa 中表达下调。相反,MMP-2 和 TIMP-2 的过表达与较高的 Gleason 评分肿瘤有关。我们推测,金属蛋白酶表达的改变可能在控制与前列腺癌发生和肿瘤行为相关的组织动态平衡方面具有重要意义。

相似文献

1
Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.MMP-2 及其调节因子 TIMP2、MT1-MMP 和 IL-8 的低表达与前列腺癌有关。
Int Braz J Urol. 2012 Mar-Apr;38(2):167-74. doi: 10.1590/s1677-55382012000200004.
2
MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer.MMP-9 的过度表达与 TIMP-1 和 RECK 的表达不足与前列腺癌的预后相关。
Int J Biol Markers. 2011 Oct-Dec;26(4):255-61. doi: 10.5301/JBM.2011.8831.
3
Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer.局部前列腺癌中TIMP-1免疫表达缺失与肿瘤复发
Int Braz J Urol. 2015 Nov-Dec;41(6):1088-95. doi: 10.1590/S1677-5538.IBJU.2014.0451.
4
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer.MMP-9 和 IL-8 的表达增加与膀胱癌的不良预后相关。
BMC Urol. 2012 Jun 13;12:18. doi: 10.1186/1471-2490-12-18.
5
Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.基质金属蛋白酶(MMP - 2和 - 9)及其抑制剂(TIMP - 1和 - 2)在前列腺癌组织中的表达
Prostate Cancer Prostatic Dis. 2003;6(3):217-22. doi: 10.1038/sj.pcan.4500657.
6
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.基质金属蛋白酶(MMP - 2、MMP - 9、MT1 - MMP)及其抑制剂(TIMP - 1、TIMP - 2)在卵巢常见上皮性肿瘤中的表达
Int J Oncol. 2000 Oct;17(4):673-81.
7
[Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer].[基质中MMP-2、MT1-MMP和TIMP-2免疫标记在临床局限性前列腺癌中的预后价值]
Prog Urol. 2005 Apr;15(2):250-4.
8
CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.CD147、基质金属蛋白酶-1、基质金属蛋白酶-2和基质金属蛋白酶-9蛋白表达作为人类前列腺癌的重要预后因素。
Oncology. 2008;75(3-4):230-6. doi: 10.1159/000163852. Epub 2008 Oct 14.
9
Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.基质金属蛋白酶-2(MMP-2)的表达与激活及其与膜型1基质金属蛋白酶(MT1-MMP)的共定位与黑色素瘤进展相关。
J Pathol. 2000 Jul;191(3):245-56. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH632>3.0.CO;2-#.
10
Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 responses to traumatic skeletal muscle injury.金属蛋白酶-2、-9和-14以及金属蛋白酶组织抑制剂-2的mRNA和蛋白质水平变化对创伤性骨骼肌损伤的反应。
Am J Physiol Cell Physiol. 2009 Dec;297(6):C1501-8. doi: 10.1152/ajpcell.00217.2009. Epub 2009 Sep 30.

引用本文的文献

1
Progress in Precision Medicine for Head and Neck Cancer.头颈癌精准医学的进展
Cancers (Basel). 2024 Nov 4;16(21):3716. doi: 10.3390/cancers16213716.
2
The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.细胞外基质和整合素黏附复合体相关分子在前列腺癌生物标志物发现中的潜力
Biomedicines. 2023 Dec 28;12(1):79. doi: 10.3390/biomedicines12010079.
3
The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines.
鸢尾素对前列腺癌细胞系增殖、凋亡及转移标志物表达的影响
Oncol Ther. 2022 Dec;10(2):377-388. doi: 10.1007/s40487-022-00194-4. Epub 2022 Apr 25.
4
Menin Enhances Androgen Receptor-Independent Proliferation and Migration of Prostate Cancer Cells.Menin 增强雄激素受体非依赖性前列腺癌细胞的增殖和迁移。
Mol Cells. 2022 Apr 30;45(4):202-215. doi: 10.14348/molcells.2021.0206.
5
The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.金属蛋白酶超家族在前列腺癌进展中的作用:一项类似系统综述
Int J Mol Sci. 2021 Mar 30;22(7):3608. doi: 10.3390/ijms22073608.
6
Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study.血浆细胞外囊泡衍生 TIMP-1 mRNA 作为透明细胞肾细胞癌的预后生物标志物:一项初步研究。
Int J Mol Sci. 2020 Jun 29;21(13):4624. doi: 10.3390/ijms21134624.
7
SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.SHCBP1 促进肿瘤细胞增殖、迁移和侵袭,并与前列腺癌不良预后相关。
J Cancer Res Clin Oncol. 2020 Aug;146(8):1953-1969. doi: 10.1007/s00432-020-03247-1. Epub 2020 May 23.
8
Genistein treatment duration effects biomarkers of cell motility in human prostate.金雀异黄素处理时间对人前列腺细胞运动相关生物标志物的影响。
PLoS One. 2019 Mar 27;14(3):e0214078. doi: 10.1371/journal.pone.0214078. eCollection 2019.
9
Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.趋化因子 CXCL3 以自分泌/旁分泌的方式介导前列腺癌细胞增殖、迁移和基因表达变化。
Int Urol Nephrol. 2018 May;50(5):861-868. doi: 10.1007/s11255-018-1818-9. Epub 2018 Mar 9.
10
Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer.局部前列腺癌中TIMP-1免疫表达缺失与肿瘤复发
Int Braz J Urol. 2015 Nov-Dec;41(6):1088-95. doi: 10.1590/S1677-5538.IBJU.2014.0451.